With regards to a potential BO, I'm in the same camp as those who would reject just about any offer at this time. As many have already said, this company has so much potential and could realize incredible gains over the next couple of years. I could be wrong, but I'm thinking the acceleration clause is to protect them more against a hostile takeover than it is due to a buyout. If they (NP, MM, and the board) came to an agreement with a potential buyer, they could include the language in the contract that would protect any of the executive staff for termination without cause.
But if I'm wrong, I'm still not too concerned of a BO at this time for two reasons: 1) it would have to be approved by a majority of shareholders, and I'm not convinced they'd have the votes, especially from reading the opinions on this board, and 2) it would have to happen within the next week or two, because after we get the Covid trial results and we up list, the share price will be climbing so fast that setting a firm price would be like chasing a squirrel in the backyard. They'll never catch up with the price.
Just my two cents...
(5)
(0)
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.